Atlas Trials

Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)

Clinical trial NCT04668209 · TERMINATED

Trial details

NCT number
NCT04668209
Sponsor
University of Arizona
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Coronavirus
Start date
2021-01-21
Primary completion
2022-06-30
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.